New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
10:01 EDTFLXN, DGX, IBP, CNCE, HAR, LINTA, TLMR, LH, HSNI, EGRXOn The Fly: Analyst Initiation Summary
Concert Pharmaceuticals (CNCE) initiated with a Buy at UBS and an Outperform at JMP Securities... Eagle Pharmaceuticals (EGRX) initiated with a Buy at Cantor and an Overweight at Piper Jaffray... Talmer Bancorp (TLMR) initiated with an Outperform at Keefe Bruyette, an Overweight at JPMorgan, a Strong Buy at Raymond James and an Outperform at RBC Capital... HSN, Inc. (HSNI) initiated with a Buy at UBS... Installed Building Products (IBP) initiated with a Buy at Deutsche Bank and a Neutral at SunTrust... Liberty Interactive (LINTA) initiated with a Buy at UBS and Craig-Hallum... Flexion (FLXN) initiated with a Buy at Needham... LabCorp (LH) assumed with a Neutral at Piper Jaffray... Quest Diagnostics (DGX) assumed with a Neutral at Piper Jaffray... Harman (HAR) initiated with an Outperform at Raymond James.
News For CNCE;EGRX;TLMR;IBP;HSNI;LINTA;DGX;LH;HAR;FLXN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
July 7, 2015
08:07 EDTLHLabCorp and Epic Sciences sign agreement
Subscribe for More Information
July 6, 2015
06:41 EDTEGRXEagle Pharmaceuticals price target raised to $94 from $75 at Piper Jaffray
Subscribe for More Information
July 2, 2015
13:19 EDTEGRXCantor lowers sales assumptions for Eagle's Angiomax version
After an appeals court invalidated the Angiomax patents held by The Medicines Company (MDCO), Cantor Fitzgerald lowered its price target for Eagle Pharmaceuticals (EGRX) to $92 from $95 to reflect more modest sales assumptions for the company's version of Angiomax. Cantor had previously modeled a more favorable for Eagle whereby there were no generic entrants until 2019. The firm, however, still sees the stock as undervalued and keeps a Buy rating on the name.
June 30, 2015
19:32 EDTDGXQuest to acquire MemorialCare's laboratory outreach service business
Quest Diagnostics and MemorialCare Health System announced they have entered into a definitive agreement for Quest to acquire MemorialCare Health System's laboratory outreach service business. The transaction is expected to be neutral to earnings in 2015. Quest and MemorialCare Health System expect to complete the acquisition in August. Financial terms were not disclosed.
June 25, 2015
08:09 EDTHARHarman board increases annual dividend 6% to $1.40 per share
Subscribe for More Information
June 24, 2015
08:58 EDTIBPInstalled Building Products management to meet with Deutsche Bank
Subscribe for More Information
June 23, 2015
10:00 EDTDGXOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
07:27 EDTIBPInstalled Building Products management to meet with Deutsche Bank
Subscribe for More Information
07:25 EDTDGX, LHPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
06:13 EDTDGXQuest Diagnostics downgraded to Neutral from Buy at Goldman
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use